Patchev, V K <br/><br/>
Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events.  [electronic resource] 

 -  The Journal of clinical investigation  Mar 1997 
 - 962-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI119261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex--metabolism<br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Anxiety<br/>Behavior, Animal--drug effects<br/>Corticotropin-Releasing Hormone--genetics<br/>Desoxycorticosterone--analogs & derivatives<br/>Female<br/>GABA Antagonists--metabolism<br/>Glucocorticoids--physiology<br/>Hippocampus--metabolism<br/>Humans<br/>Hypothalamus--metabolism<br/>In Situ Hybridization<br/>Infant, Newborn<br/>Male<br/>Neurosecretory Systems--drug effects<br/>Pregnancy<br/>RNA, Messenger--analysis<br/>Rats<br/>Rats, Wistar<br/>Receptors, GABA--physiology<br/>Receptors, Glucocorticoid--genetics<br/>Stress, Physiological--physiopathology<br/>Transcription, Genetic